August 19, 2020
A total of 13 drugs will newly join Japan’s NHI price list on August 26, with a key reimbursement policy panel giving them the thumbs-up on August 19, including Novartis’ heart failure treatment Entresto (sacubitril valsartan sodium hydrate). Four of...read more